Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Journal Information
Full Title: Hereditas
Abbreviation: Hereditas
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethical approval and consent to participateThe studies involving human participants were reviewed and approved by Institutional Review Board of the First Affiliated Hospital of Nanchang University. Approval no: (2022) CDYFYYLK (10-011). Consent for publicationAll authors consent to the publication of this study. Competing interestsAll authors declare that they have no conflict of interest related to this manuscript. Competing interests All authors declare that they have no conflict of interest related to this manuscript."
"Funding This study was supported by the Science and Technology Plan Project of Jiangxi Provincial Health and Health Commission (202130209)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025